Clinical Trial Update: De-Escalation Postoperative Radiotherapy for Oral Squamous Cell Carcinoma With pCR/MPR. [Phase 2]

View source ↗

Summary

This Phase 2 trial assesses whether de-escalated postoperative radiotherapy is effective for oral squamous cell carcinoma patients who achieve pathologic comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Squamous Cell Carcinoma

Snippet

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Conditions: De-escalated Radiotherapy; Head and Neck Cancer | Phase 2 | Status: RECRUITING